Skip 
Navigation Link
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Flu Shot Could Help Your Kid Avoid HospitalHealth Tip: Safety Advice for the HolidaysAccurate Diagnosis Seen With Photographs of Skin ConditionsIf Dad Has Depression, Kids Might Develop It, TooKids Still Getting Risky Painkiller After TonsillectomySport Sampling in Children Tied to More Exercise in AdolescenceMusic, Video Help Sixth-Graders Master Hands-Only CPRChildhood Spanking Could Heighten Adult Mental Health WoesHealth Tip: Prevent Germs at the Doctor's OfficeInfluenza Vaccines in Pediatric ERs Likely Cost-EffectiveCooling Down Sibling Rivalries When They Heat UpDoes All That Social Media Time Harm Young Minds?Helping Children Cope When a Mass Tragedy Strikes'Good Ole Days' Were Better for Kids' Health, Adults SayTV Ads Still Push Unhealthy Foods at KidsSchool-Based Food Co-op Tied to Improved Diets in ChildrenWorking With Your School NurseChildren of Immigrants Less Likely to be Up-to-Date on ShotsHealth Tip: Have Fun on Halloween, Despite AsthmaHelmets Too Rarely Used in Baseball and SoftballKids' High Blood Pressure Often OverlookedKeep Halloween Spooky, But SafeKids' Food Allergies, Especially to Peanuts, Are on the RiseHealth Tip: Talk To Your Kids About a TragedyHealth Tip: Defining CyberbullingASA: Botox Injections Beneficial for Migraine in ChildrenTrauma Takes a Toll on Half of U.S. KidsMedical Marijuana Won't Help Most Sick KidsScoliosis Screenings Can Help Catch Spine Problem EarlyArthritis Can Strike ChildrenPlan an Allergy-Safe Halloween for Your ChildHappier Mealtimes, Healthier Eating for KidsAAP Releases List of Often-Unnecessary TestsUSPSTF Recommends Counseling Youth on Sun Protection BehaviorChildhood Obesity Up Worldwide Almost 10-Fold Over 4 DecadesStart Skin Cancer Prevention Early, Health Experts SayHealth Tip: Getting Enough SleepSurviving Congenital Heart Disease as Child Not a Ticket to Good HealthHealth Tip: Children and Screen UseHealth Tip: Suggestions for a Healthy HalloweenMaking Halloween a Treat for Kids With DiabetesHealth Tip: Learn Symptoms of Childhood SinusitisChildhood 'Growth' Tests Not Always NecessaryMore U.S. Measles Cases From No Vaccine vs. Imported DiseaseMeasles Making a Comeback in the United StatesReassuring Kids After Another Senseless TragedyBilingual Kids Learn New Languages BetterGirls' Sports-Related Concussions May Last Twice As LongTeens Mixed Up With the Law May Fall Through Medicaid CracksLooking at Laughter for Clues to Anti-Social Behavior
Questions and AnswersLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Researchers Target Zolmitriptan Dosing for Pediatric Migraine


HealthDay News
Updated: Jun 8th 2017

new article illustration

THURSDAY, June 8, 2017 (HealthDay News) -- In a report published online June 5 in the Journal of Clinical Pharmacology, recommended dosing regimens of zolmitriptan are suggested for children with migraine.

Wangda Zhou, Ph.D., from AstraZeneca Pharmaceuticals in Waltham, Mass., and colleagues developed a population pharmacokinetic model for zolmitriptan and its active metabolite in adults and adolescents, and provided appropriate dosing regimens for use in clinical trials in 6- to 11-year-old children. Data from a single-dose study involving 5.0-mg zolmitriptan nasal spray (ZNS) conducted in adult and adolescents with migraine were applied.

The researchers found that adults and adolescents had similar plasma concentration profiles of zolmitriptan and its metabolite 183C91. The estimated typical apparent volume of distribution and clearance of zolmitriptan were 136 L and 121 L/h, respectively; between-subject variability was 56.5 and 42.6 percent, respectively. To achieve exposures similar to those of the adult and adolescent population administered 5.0 mg ZNS, a body-weight dosing scheme of 5.0 and 2.5 mg ZNS is recommended in children greater than and less than 50 kg, respectively.

"The recommended doses for children to achieve exposure similar to that observed in adults given 2.5 mg ZNS are 2.5 mg (≥50 kg) and 1.0 mg (15 to 50 kg)," the authors write. "These dosing regimens could be used in future clinical trials."

The authors disclosed financial ties to AstraZeneca, a manufacturer of zolmitriptan.

Abstract
Full Text (subscription or payment may be required)